Diabetes and extracellular matrix in NASH
Diabetes and extracellular matrix in NASH
批准号:
10663615
负责人:
Natalie J. Torok
金额:
$30.43万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-03-20 至 2023-01-31
关键词:
3-DimensionalAddressAdvanced Glycosylation End ProductsAffectAnimal ModelArchitectureBehaviorCell ProliferationCellsCharacteristicsCirrhosisClinicalCollagen Type IDataDepositionDiabetes MellitusDietEnvironmentExtracellular MatrixGenderHumanHydrogelsIncidenceInjectionsLeadLinkLiverMalignant NeoplasmsMetabolismModelingNeoplasm MetastasisNon-Insulin-Dependent Diabetes MellitusOutcomePathway interactionsPatientsPhenotypePrimary carcinoma of the liver cellsProductionPropertyRelaxationRisk FactorsShapesSignal TransductionStressSystemTestingTherapeuticTimeTumor BurdenWorkbasebeta catenincarcinogenicitycell behaviorcell transformationcrosslinkdiabeticglycemic controlimprovedin vivoliver cancer modelliver injurymigrationmutantnonalcoholic steatohepatitisnovelpatient populationreceptorresponsetranscriptome sequencingtumor diagnosisviscoelasticity
中文摘要
非酒精性脂肪性肝炎(NASH)是肝细胞癌(HCC)的危险因素,通常发生在肝细胞癌前阶段。由于这一患者群体没有进行筛查,这些肿瘤通常在晚期被诊断出来。我们试图了解不同的途径如何在非酒精性NASH中创造一个促致癌环境。我们之前已经证明,晚期糖基化终末产物(AGEs)在糖尿病前期T2 DM/NASH患者和动物模型中是坏死性炎症和氧化性肝损伤的关键。AGE清除受体AGER 1在NASH中下调,加速AGE沉积,并在体内纠正AGER 1改善肝损伤。为了研究高AGE环境如何为转化细胞创造容许条件,我们在流体动力学注射hMET/突变体β-连环蛋白之前调节饮食/AGE含量。高AGE背景诱导早期和更具侵袭性的HCC,AGE积累与基质动力学的显著变化有关。我们发现AGE抑制逆转了体内基质粘弹性的变化,降低了肿瘤负荷。我们将检验这一假设,即在非糖尿病性T2 DM/NASH中,AGEs有助于增加基质粘弹性和基质细胞变化,从而创造一个促侵袭环境。在目标1中,我们将建立并研究一种新的NASH模型,以研究饮食/AGE含量、基质粘弹性、性别与HCC特征以及结果之间的关联。在目标2中,我们提出开发具有可调粘弹性的3D水凝胶系统,以研究细胞形状/细胞骨架变化、侵袭和迁移。使用RNAseq数据,我们将探索赋予侵入和迁移特性的关键基质细胞信号。这些研究将首次概述粘弹性如何增强促侵袭性小生境,并确定驱动HCC侵袭的关键基质细胞信号。
英文摘要
Non-alcoholic steatohepatitis (NASH) is a risk factor for hepatocellular carcinoma (HCC) that often arises at a pre-cirrhotic stage. As this patient population is not screened, often these tumors are diagnosed at a late stage. We seek to understand how distinct pathways could create a pro-carcinogenic environment in non-cirrhotic NASH. We previously showed that advanced glycation end products (AGEs) in patients with pre-cirrhotic T2DM/NASH and in an animal model, are key to necroinflammation and oxidative liver injury. The AGE clearance receptor AGER1 was downregulated in NASH, accelerating AGE deposition, and correcting AGER1 in vivo improved liver injury. To study how high AGE environment creates permissive conditions for transformed cells, we modulated the diet/AGE content prior to hydrodynamic injection of hMET/mutant β-catenin. High AGE background induced an earlier and more invasive HCC, and AGE accumulation was linked to significant changes in matrix dynamics. We found that AGE inhibition reversed changes in matrix viscoelasticity in vivo and lowered the tumor burden. We will test the hypothesis that in non-cirrhotic T2DM/NASH AGEs contribute to an increase in matrix viscoelasticity and matricellular changes creating a pro-invasive environment. In Aim 1, we will establish and investigate a novel NASH model to study the association between diet/AGE content, matrix viscoelasticity, gender and HCC characteristics as well as outcomes. In Aim 2 we propose to develop a 3D hydrogel system with tunable viscoelasticity to study cellular shape/cytoskeletal changes, invasion and migration. Using RNAseq data we will explore the key matricellular signals that confer invasive and migratory properties. These studies will for the first time outline how viscoelasticity elicits a pro-invasive niche, and identify the key matricellular signals that drive invasion of HCC.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1152/ajpgi.00050.2016
发表时间:
2016-10
期刊:
American journal of physiology. Gastrointestinal and liver physiology
影响因子:
--
作者:
[Natalie J Torok]
通讯作者:
Natalie J Torok
DOI:
10.1053/j.gastro.2015.04.009
发表时间:
2015-08
期刊:
Gastroenterology
影响因子:
29.4
作者:
[Bettaieb A, Jiang JX, Sasaki Y, Chao TI, Kiss Z, Chen X, Tian J, Katsuyama M, Yabe-Nishimura C, Xi Y, Szyndralewiez C, Schröder K, Shah A, Brandes RP, Haj FG, Török NJ]
通讯作者:
Török NJ
Update on Alcoholic Hepatitis.
酒精性肝炎的最新进展。
DOI:
10.3390/biom5042978
发表时间:
2015
期刊:
Biomolecules
影响因子:
5.5
作者:
[Torok,NatalieJ]
通讯作者:
Torok,NatalieJ
Vascular adhesion protein 1 in nonalcoholic steatohepatitis: a novel biomarker?
非酒精性脂肪性肝炎中的血管粘附蛋白 1:一种新型生物标志物?
DOI:
10.1002/hep.27942
发表时间:
2015
期刊:
Hepatology (Baltimore, Md.)
影响因子:
--
作者:
[Torok,NatalieJ]
通讯作者:
Torok,NatalieJ
DOI:
10.1038/srep46144
发表时间:
2017-04-06
期刊:
Scientific reports
影响因子:
4.6
作者:
[Sasaki Y, Dehnad A, Fish S, Sato A, Jiang J, Tian J, Schröder K, Brandes R, Török NJ]
通讯作者:
Török NJ
共 6 条
Matrix in pre-cirrhotic HCC
-
批准号:10578389
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2023
-
负责人:Natalie J. Torok
-
依托单位:
Novel sterile inflammatory pathways in alcoholic hepatitis
-
批准号:10427122
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease
-
批准号:8732139
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease
-
批准号:8884377
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
Novel sterile inflammatory pathways in alcoholic hepatitis
-
批准号:10554317
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
Novel sterile inflammatory pathways in alcoholic hepatitis
-
批准号:9890961
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease
-
批准号:9339550
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease
-
批准号:9840797
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
The Role of TNF alpha Converting Enzyme in Alcoholic Liver Disease
-
批准号:8974372
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:7779431
-
项目类别:
-
资助金额:$38.25万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:8045365
-
项目类别:
-
资助金额:$31.15万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:8928401
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:8433381
-
项目类别:
-
资助金额:$29.93万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
AGEs/RAGE in Progressive NASH
-
批准号:9127009
-
项目类别:
-
资助金额:$35.33万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:8616053
-
项目类别:
-
资助金额:$31.02万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Phagocytosis and NOX2 in Liver Fibrogenesis
-
批准号:8225287
-
项目类别:
-
资助金额:$31.08万
-
财政年份:2010
-
负责人:Natalie J. Torok
-
依托单位:
Apoptosis and Liver Fibrogenesis
-
批准号:7896897
-
项目类别:
-
资助金额:$4.97万
-
财政年份:2009
-
负责人:Natalie J. Torok
-
依托单位:
The Role of NOX2 in Liver Fibrosis
-
批准号:7435025
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2008
-
负责人:Natalie J. Torok
-
依托单位:
The Role of NOX2 in Liver Fibrosis
-
批准号:7561688
-
项目类别:
-
资助金额:$7.6万
-
财政年份:2008
-
负责人:Natalie J. Torok
-
依托单位:
Apoptosis and Liver Fibrogenesis
-
批准号:7561687
-
项目类别:
-
资助金额:$12.45万
-
财政年份:2005
-
负责人:Natalie J. Torok
-
依托单位:
海外基金